Lunch Seminar Hosted By Cytivia
Speaker: Yasser Kehail
Single Use & Enterprise Business Development Leader
Bio: Yasser has over 12 years of experience in cell culture manufacturing, development, and optimization. He currently supports clients working on different therapeutic modalities, such as monoclonal antibodies, plasmid DNA, vaccines, and viral vectors, consulting specifically on upstream scale-up strategies and technology transfer. Yasser began his career in cell culture manufacturing at Biogen. He then moved to Upstream PD at Amgen before joining Cytiva, formerly part of GE Healthcare’s Life Sciences business, in 2014.
*You must be a registered attendee of Gene Therapy for Rare Disorders to attend the Lunch Seminar.
Register here for the lunch and your place will be confirmed by a member of the team. If you have any questions email: email@example.com